[Seroprevalence and risk factor for hepatitis C in Nogales, Sonora].

Jesús Antonio Pérez-Mercado, Diana Lizeth Gallegos-Durazo, Jorge Rafael Hernández-Donnadieu, Edgar Daniel Copado-Villagrana
{"title":"[Seroprevalence and risk factor for hepatitis C in Nogales, Sonora].","authors":"Jesús Antonio Pérez-Mercado, Diana Lizeth Gallegos-Durazo, Jorge Rafael Hernández-Donnadieu, Edgar Daniel Copado-Villagrana","doi":"10.5281/zenodo.11397093","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hepatitis C Virus (HCV) infection represents a global public health problem, but in Mexico, the Ministry of Health through the National Epidemiological Surveillance System (SINAVE) only reports the distribution of incident cases by state, sex and epidemiological week.</p><p><strong>Objective: </strong>To determine the seroprevalence and factors associated with HCV in beneficiaries of a Family Medicine Unit of the Mexican Social Security Institute (IMSS) in the city of Nogales, Sonora, located on the border between Mexico and the United States.</p><p><strong>Material and methods: </strong>Cross-sectional study that included 145 beneficiaries with rapid HCV antibody test results. Information on risk factors was obtained through direct questioning. To compare groups of reactive and non-reactive patients, Fisher's Exact Test was used and a Logistic Regression model to determine Odds Ratio (OR) values. A P value <0.05 was considered statistically significant.</p><p><strong>Results: </strong>A seroprevalence of 2.8% (95%CI: 0.8 - 6.9) was determined and through the logistic regression model it was found that the history of transfusions (OR: 151.2, 95%CI: 5.9 - 3.858.0) and the use of intranasal drugs (OR: 20.81, 95%CI: 1.3 - 331.3) increase the risk of infection.</p><p><strong>Conclusions: </strong>The seroprevalence of HCV in Nogales is higher than that of the rest of Mexico. Recent studies establish a history of transfusion as a risk factor, but few have explored intranasal drug use.</p>","PeriodicalId":94200,"journal":{"name":"Revista medica del Instituto Mexicano del Seguro Social","volume":"62 4","pages":"1-4"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista medica del Instituto Mexicano del Seguro Social","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5281/zenodo.11397093","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Hepatitis C Virus (HCV) infection represents a global public health problem, but in Mexico, the Ministry of Health through the National Epidemiological Surveillance System (SINAVE) only reports the distribution of incident cases by state, sex and epidemiological week.

Objective: To determine the seroprevalence and factors associated with HCV in beneficiaries of a Family Medicine Unit of the Mexican Social Security Institute (IMSS) in the city of Nogales, Sonora, located on the border between Mexico and the United States.

Material and methods: Cross-sectional study that included 145 beneficiaries with rapid HCV antibody test results. Information on risk factors was obtained through direct questioning. To compare groups of reactive and non-reactive patients, Fisher's Exact Test was used and a Logistic Regression model to determine Odds Ratio (OR) values. A P value <0.05 was considered statistically significant.

Results: A seroprevalence of 2.8% (95%CI: 0.8 - 6.9) was determined and through the logistic regression model it was found that the history of transfusions (OR: 151.2, 95%CI: 5.9 - 3.858.0) and the use of intranasal drugs (OR: 20.81, 95%CI: 1.3 - 331.3) increase the risk of infection.

Conclusions: The seroprevalence of HCV in Nogales is higher than that of the rest of Mexico. Recent studies establish a history of transfusion as a risk factor, but few have explored intranasal drug use.

[索诺拉州诺加莱斯的丙型肝炎血清流行率和风险因素]。
背景:丙型肝炎病毒(HCV)感染是一个全球性的公共卫生问题,但在墨西哥,卫生部通过国家流行病监测系统(SINAVE)仅报告了按州、性别和流行病学周划分的病例分布情况:目的:确定位于墨西哥和美国边境索诺拉州诺加利斯市的墨西哥社会保障局(IMSS)家庭医学科受益人的血清阳性率以及与丙型肝炎病毒相关的因素:横断面研究,包括 145 名有快速 HCV 抗体检测结果的受益人。通过直接询问获得了有关风险因素的信息。为了比较有反应和无反应患者的组别,采用了费雪精确检验法和逻辑回归模型来确定几率比(OR)值。P 值 结果:通过逻辑回归模型发现,输血史(OR:151.2,95%CI:5.9 - 3.858.0)和使用鼻内药物(OR:20.81,95%CI:1.3 - 331.3)会增加感染风险:结论:诺加利斯的丙型肝炎病毒血清阳性率高于墨西哥其他地区。最近的研究证实输血史是一个风险因素,但很少有研究探讨鼻内吸毒问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信